Abstract
Papillar serous carcinoma of peritoneum (PSPC) is an unfrequent neoplasm, histologically similar to papillar serous carcinoma of ovarium. It presents as peritoneal carcinomatosis without evident tumoral focus. Management of PSPC is similar to ovaric neoplasms, although prognosis should be worse. Long-term survival has been described with cytoreductive surgery and adjuvant chemotherapy with platinum. We present hereby 2 cases of PSPC.
MeSH terms
-
Aged
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Agents, Phytogenic
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carboplatin / administration & dosage
-
Carboplatin / therapeutic use
-
Carcinoma, Papillary* / diagnostic imaging
-
Carcinoma, Papillary* / drug therapy
-
Carcinoma, Papillary* / mortality
-
Carcinoma, Papillary* / surgery
-
Chemotherapy, Adjuvant
-
Cisplatin / administration & dosage
-
Cisplatin / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Middle Aged
-
Paclitaxel / administration & dosage
-
Paclitaxel / therapeutic use
-
Peritoneal Neoplasms* / diagnostic imaging
-
Peritoneal Neoplasms* / drug therapy
-
Peritoneal Neoplasms* / mortality
-
Peritoneal Neoplasms* / surgery
-
Postoperative Care
-
Radiography, Abdominal
-
Time Factors
-
Tomography, X-Ray Computed
-
Topotecan / administration & dosage
-
Topotecan / therapeutic use
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Antineoplastic Agents, Phytogenic
-
Topotecan
-
Carboplatin
-
Paclitaxel
-
Cisplatin